Steven Eric Finkelstein, MD, FACRO
Dr. Finkelstein matriculated in a combined medical degree program when he was 16, and graduated cum laude from Michigan in 1997. His initial advanced oncologic training was at the National Cancer Institute in Surgical Oncology and Immunotherapy. Dr. Finkelstein has published journal articles and book chapters resulting in 5000+ reference citations. Recognizing the impact he could have as a radiation oncologist, Dr. Finkelstein joined Moffitt Cancer Center completing chief residency and 21st Century Oncology as National Director of Translational Research. After bridging gaps for patients in clinical trial availability in community oncology settings, he became Chief Science Officer in 2014. He has received numerous awards across specialties including 2015 ACRO highest-rated-abstract. He serves as co-Chair NRG-Immunotherapy-Committee, Chair SWOG-Radiation-STG-Committee, editor ASCO Publications, and Editor-In-Chief Contemporary Radiation Oncology. In 2017, he was recruited as Cancer Center Director for BRCC. He is truly honored to serve ACRO as Co-Chair of the 2018 and 2019 ACRO annual meetings.
Dr. Finkelstein’s Statement
Having spent the first half of my professional career in academia and the second in private practice, and having dealt with the legislature and with industry on a daily basis gives me a unique perspective of the status of the profession to serve ACRO members better to face an ever-changing environment. My career in multiple oncologic arenas has given me broad personal exposure to radiation oncology, immunotherapy, surgical oncology, and medical oncology, with a unique prospective on multidisciplinary integration. I am fortunate to be at the forefront of our specialty on the confluence of the immune system and radiotherapy; this work seeks to enlighten us and expand indications for radiotherapy. Key priorities for the Board are threefold: facilitate awareness of limitations of current practices; determine key questions that need to be answered; and build toward an environment where all can do the work much needed by our patients. I submit my candidacy to you, the members of ACRO, for election to the Board of Chancellors, to help forge our future together.
Arve Gillette, MD, FACRO
Dr. Arve Gillette is an ACRO Fellow and a Gold Medal recipient. He received his MD at the University of Michigan in 1976 and completed a residency in Radiation Oncology and a fellowship in Medical Oncology at John Hopkins Hospital and a brachytherapy fellowship at Vanderbilt hospital. He is board certified in Internal Medicine, Medical Oncology, and Radiation Oncology. He is a founding member of American College of Radiation Oncology in 1990, and served on the Board of Chancellors from 1997 through 2015, as president-elect, president and chairman. He has also served as chairman of the Government Relations and Membership Committees, and as Medical Director of ACRO Accreditation during its reorganization in 2010.
In 2003, Dr. Gillette was intimately involved in the reorganization of ACRO when it changed management support and reorganized its annual meeting structure to include cutting edge radiation oncology technology suitable for private practice. He has been responsible for much of the infrastructure that ACRO currently provides, and served as managing editor of the ACRO Practice Management Guide, 1999-2001
Dr. Gillette practiced for many years in Indianapolis, IN, in a large hospital based private practice group, and during that period he was president of the Indiana State Radiation Oncology Society. For the past 12 years, he has practiced with Texas Oncology, Dallas, TX, for which he serves on the Radiation Services and the Quality Committees. Dr. Gillette continues to be active politically, and has made numerous visits to Capitol Hill and Congress to promote appropriate Radiation Oncology billing, coding, and supervision.
If elected, Dr. Gillette’s goals for ACRO include finding common ground between the needs of its members and the market forces that direct how we deliver care. He is also interested in facilitating the implementing of the current leading-edge technologies that best serve our patients. To facilitate this, he has been very much involved in appropriate billing, coding, and reimbursement for our heavily capital-intensive specialty.
Jaroslaw Hepel, MD, FACRO
Dr. Jarek Hepel serves as Director of Stereotactic Radiosurgery at Rhode Island Hospital in Providence, RI and Assistant Professor at The Warren Alpert Medical School of Brown University. Dr. Hepel received his undergraduate degree at Cornell University and medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in radiation oncology at Tufts Medical Center in Boston, MA. Dr. Hepel has particular interests in the treatment of breast cancer and the use of SRS/SBRT for various body sites. Dr. Hepel has been an active member and supporter of ACRO. He has served as reviewer and Disease Site Team Leader in Breast Cancer in the ACRO Accreditation Program for the past 6 years. Starting in fall of 2015, he has led the Accreditation Program as Medical Director maintaining high quality standards and improving the program.
Dr. Hepel’s Statement
“ACRO strives to ensure the highest quality for radiation therapy patients and promotes success in the practice of radiation oncology through education, responsible socioeconomic advocacy, and integration of science and technology in the clinical practice.” I whole-heartedly support this mission statement and will work to continue to achieve it. The practice of radiation oncology is continually undergoing changes both from favorable forces such as advancement in technology and medical knowledge as well as unfavorable forces such as growing economic pressures and changing medical re-embarrassment landscape. Through ACRO, I seek to actively address these challenges with the goals of maintaining the health of our specialty and helping guide members to maintain high quality and productive clinical practices.
J. Ben Wilkinson, MD
Dr. Wilkinson is an active member of ACRO with continued extensive involvement with the New Practitioner, Resident, and Membership Committees. He received his undergraduate and medical training in Texas (TCU and Texas A&M) followed by radiation oncology training at William Beaumont Hospital with chairman (and long-time ACRO advocate) Alvaro Martinez. Dr. Wilkinson is currently the lead radiation oncologist and medical director at Provision CARES Proton Therapy Center in Knoxville, Tennessee. Prior to joining Provision, he worked at Willis-Knighton Cancer Center and LSU Health Science Center in Shreveport, Louisiana with ACRO Fellows Lane Rosen and Sanford Katz as well as Michael Durci. Dr. Wilkinson’s clinical sites include pediatrics, CNS, breast, and prostate cancers. His areas of ongoing clinical research focus on central nervous system tumors, hypofractionation for prostate and breast cancers. Apart from clinical work, Dr. Wilkinson is active in his community and church as well as a strong supporter and board member of Radiating Hope / Radiating Hope Society.
Dr. Wilkinson’s Statement
ACRO is an incredibly special organization to me that has been a core component of my professional development as a radiation oncologist. I count some of my closest professional friends and mentors as ACRO members. My service to the College includes active membership on the Resident, New Practitioner, Membership, Development, and the Annual Meeting Scientific Program committees including serving as chair of both Resident and New Practitioner Committees and Vice-Chair of the Membership Committee. This work over the past eight years has led to the introduction of sub-committee structure for the Resident Committee, significant growth in membership of early-career radiation oncologists, development of the initial resident Mentorship Program for ACRO together with John Ng, and introduction of the Job Link program with Brandon Prendergast at our annual meeting. During residency, I also had had the opportunity to travel to Washington, D.C. with ACRO leaders as part of our national advocacy efforts, serve as a resident committee-liaison to the Board of Chancellors, as well as piloting a Leadership Development Program for the College. If elected to the ACRO Board, I would work hard to represent all segments of our membership with special emphasis on continued growth of the New Practitioner segment of our College.